Building REsilience against MEntal illness during ENDocrine-sensitive life stages

HealthHORIZON-RIAID: 101057604
EC Contribution
€108,682
Consortium Size
18 orgs
Start Year
2023
Summary

Mental illnesses represent a huge burden for society, the economy, and the aMental illnesses represent a huge burden for society, the economy, and the affected individuals. To significantly increase citizens? mental health, today?s symptom-based diagnoses need to be complemented by biological criteria accounting for individual and sex differences. Furthermore, early detection and prevention measures need to be improved. RE-MEND addresses the current gaps and challenges with an interdisciplinary approach by: i) focussing on four critical life stages in which an individual?s susceptibility to mental illness is strongly influenced by changes in endocrine signalling, including sex hormones, namely early life, puberty, peripartum, and transition into old age; ii) integrating data from large population-based longitudinal cohort studies allowing for discovery of risk and protective factors as well as biological patterns that influence mental states in the general population across these life stages; iii) complementing epidemiological with experimental studies to establish correlative and causative links leading to mechanistic understanding; iv) using advanced biostatistics as well as machine learning and artificial intelligence for data integration and biomarker and drug target discovery; v) combining the biological approaches with communication science studies to efficiently translate its results to societal impact. Ultemately, RE-MEND will result in: i) Significantly increased mental health literacy among stakeholders and citizens; ii) Validated biomarkers for assessing mental health state and its predisposition as well as more accurate diagnoses and personalised preventive and therapeutic measures; iii) Recommendations for early detection, better prevention, and drug design strategies to protect vulnerable individuals from mental illness in sensitive life stages; and iv) strategies on how these advances can be used to decrease stigma and increase prevention behaviour.

Consortium (18)

Project Results (18)

Source: CORDIS, the EU research results database.

Publications (13)
The role of gene-environment interactions in endocrine-sensitive life stages for shaping mental health: focus on the RE-MEND project
Frontiers in Psychiatry· 2026DOI
Khawla Abualia, Andrea Cediel-Ulloa, Philip Allsopp, Angelika Augustine, Jonas Bergquist, Carl-Gustaf Bornehag, Karin Broberg, Nicolò Caporale, Erika Comasco, Diego di Bernardo, Rosário Domingues, Elina Drakvik, Chris Gennings, Malin Gingnell, Daniel Globisch, Maria Kippler, Emeir McSorley, Maria Mulhern, Hitesh V. Motwani, Ivan Nalvarte, Anna Oudin, Anisur Rahman, Doreen Reifegerste, Theo Rein, Alkistis Skalkidou, J. J. Strain, Giuseppe Testa, Liudmyla Tsiukalo, Edwin van Wijngaarden, Alison Yeates, Joëlle Rüegg, Philipp Antczak
The same, but different: Understanding responsibility attributions for depression with a cross-national survey in the United States and Germany
Health Policy· 2026DOI
Anna Wagner, Doreen Reifegerste, Sebastian Scherr
Association Between Intellectual Functioning and Autistic Traits in the General Population of Children
Child Psychiatry & Human Development· 2025DOI
Maria Marinopoulou, Eva Billstedt, Catrin Wessman, Carl-Gustaf Bornehag, Maria Unenge Hallerbäck
Differentially expressed transcripts associated with depressive symptoms during pregnancy and postpartum
Molecular Psychiatry· 2025DOI
Richelle D. Björvang; Maria Vrettou; Xabier Bujanda Cundin; Eugenio Del Prete; Joëlle Rüegg; Susanne Lager; Diego di Bernardo; Erika Comasco; Alkistis Skalkidou
Environmental Research
Environmental Research· 2025DOI
Sai San Moon Lu; Erik Ekbäck; Johan Nilsson Sommar; Sara Anderson; Henrik Olstrup; Sophia Harlid; Susanna Gustafsson; Kristoffer Mattisson; Leo Stockfelt; Theo Rein; Ivan Nalvarte; Joëlle Rüegg; Anna Oudin
Environmental Research
Environmental Research· 2025DOI
Sai San Moon Lu; Erik Ekbäck; Johan Nilsson Sommar; Sara Anderson; Henrik Olstrup; Sophia Harlid; Susanna Gustafsson; Kristoffer Mattisson; Leo Stockfelt; Theo Rein; Ivan Nalvarte; Joëlle Rüegg; Anna Oudin
Prenatal exposure to endocrine disrupting chemicals and the association with behavioural difficulties in 7-year-old children in the SELMA study
Journal of Exposure Science & Environmental Epidemiology· 2025DOI
Marlene Stratmann, Fatih Özel, Maria Marinopoulou, Christian Lindh, Hannu Kiviranta, Chris Gennings, Carl-Gustaf Bornehag
ACS Chemical Neuroscience
ACS Chemical Neuroscience· 2024DOI
Theodosia Vallianatou; Carina de Souza Anselmo; Ioanna Tsiara; Nicholas B. Bèchet; Iben Lundgaard; Daniel Globisch
Identification of New Ketamine Metabolites and Their Detailed Distribution in the Mammalian Brain
ACS Chemical Neuroscience· 2024DOI
Theodosia Vallianatou, Carina de Souza Anselmo, Ioanna Tsiara, Nicholas B. Bèchet, Iben Lundgaard, Daniel Globisch
Mid-pregnancy allopregnanolone levels and trajectories of perinatal depressive symptoms
Psychoneuroendocrinology· 2024DOI
Björväng RD, Walldén Y, Fransson E, Comasco E, Sundström-Poromaa I, Skalkidou A
Nature Methods
Nature Methods· 2024DOI
Nicolò Caporale; Davide Castaldi; Marco Tullio Rigoli; Cristina Cheroni; Alessia Valenti; Sarah Stucchi; Manuel Lessi; Davide Bulgheresi; Sebastiano Trattaro; Martina Pezzali; Alessandro Vitriolo; Alejandro Lopez-Tobon; Matteo Bonfanti; Dario Ricca; Katharina T. Schmid; Matthias Heinig; Fabian J. Theis; Carlo Emanuele Villa; Giuseppe Testa
Peripheral immune cell-derived matrix metalloprotease 8 (MMP8): brain trafficking promotes depression-like behavior
Signal Transduction and Targeted Therapy· 2024DOI
Dietmar Spengler; Theo Rein
PLoS ONE
Plos One· 2024DOI
Özel F, Stratmann M, Papadopoulos FC, Rüegg J, Bornehag CG
Deliverables (4)
Data Management Plan
Websites, patent fillings, videos etc.
Documents, reports
Other Results (1)
Periodic Reporting for period 1 - Re-MEND (Building REsilience against MEntal illness during ENDocrine-sensitive life stages)